---
title: "Bafna Pharmaceuticals Ltd (BAFNAPH) — Share Price, Financials & Analysis"
symbol: "BAFNAPH"
company: "Bafna Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/BAFNAPH"
isin: "INE878I01022"
nse_symbol: "BAFNAPH"
bse_code: "532989"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 727.67
generated_at: "2026-09-13T18:57:10.064Z"
---

# Bafna Pharmaceuticals Ltd (BAFNAPH)

Canonical page: https://tapetide.com/stocks/BAFNAPH

## Company

- **NSE Symbol:** BAFNAPH
- **BSE Code:** 532989
- **ISIN:** INE878I01022
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2020-02-27
- **CEO:** Mr. Bansilal Mahaveer Chand Bafna
- **Employees:** 406
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** bafnapharma.com

## About

Incorporated in 1981, Bafna Pharmaceuticals 
Ltd manufactures finished pharmaceutical formulations[1]

## Latest Price

- **Price:** ₹301.45
- **Change:** -6.15 (-2%)
- **Open:** ₹301.45
- **Day High:** ₹301.45
- **Day Low:** ₹301.45
- **Previous Close:** ₹307.6
- **Volume:** 11743
- **As Of:** 2026-09-11T09:45:06+00:00

## Key Fundamentals

Observed at 2026-09-11T04:37:35.235278Z.

- **Market Cap:** ₹727.67 Cr
- **Classification:** Microcap
- **P/E (reported):** 90.3
- **P/E (TTM):** 91.63
- **EPS (TTM):** ₹3.29
- **Book Value:** ₹40.64
- **Price to Book:** 7.31
- **Dividend Yield:** 0%
- **ROE:** -3.68%
- **ROCE:** -3.3%
- **Debt to Equity:** 0.39
- **Revenue (yearly):** ₹42.7 Cr
- **Net Income:** ₹-1.9 Cr
- **EBITDA:** ₹1.5 Cr
- **52-Week High:** ₹318.5
- **52-Week Low:** ₹94.77
- **RSI (14):** 65.97

## Tapetide Score

- **Score:** 35 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 6 (of 4473 scored stocks)
- **Confidence:** 95%
- **Data coverage:** 90%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 35.35 | 9% |
| growth | 7.89 | 9% |
| momentum | 98.19 | 12% |
| ownership | 48.6 | 24% |
| quality | 30.53 | 22% |
| valuation | 18.09 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 7.42 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of 9.88% over last 3 years.
- Earnings include an other income of Rs.6.07 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | — | -386.67% | — |
| ebitda margin growth | 107.69% | -112% | -171.49% | 20.98% |
| net income growth | 71.43% | -90.21% | 0% | 14% |
| revenue growth | 71.83% | -2.95% | 9% | 16% |
| roce | -85.75% | -90.07% | -66.67% | -11.61% |
| roe | -72.3% | -96.42% | -50.61% | -85.96% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 40.68 | 28.44 | 41.4 | 33.29 | 40.32 | 33.19 | 39.06 | 34.62 | 35.47 | 38.29 | 42.24 | 26.58 |
| Expenses | 36.67 | 30.51 | 38.51 | 32.08 | 36.53 | 30.13 | 35.95 | 29.55 | 31.19 | 35.24 | 38.69 | 25.69 |
| Operating Profit | 4.01 | -2.07 | 2.89 | 1.21 | 3.79 | 3.06 | 3.11 | 5.07 | 4.28 | 3.05 | 3.55 | 0.89 |
| OPM % | 9.86 | -7.28 | 6.98 | 3.63 | 9.4 | 9.22 | 7.96 | 14.64 | 12.07 | 7.97 | 8.4 | 3.35 |
| Other Income | 0.16 | 0.98 | 0.52 | 0.16 | 1.02 | 0.18 | -0.76 | 0.6 | 1.18 | 1.22 | 1.76 | 1.91 |
| Interest | 0.44 | 0.58 | 0.68 | 0.65 | 0.62 | 0.64 | 0.82 | 0.91 | 0.86 | 0.86 | 1.03 | 0.94 |
| Depreciation | 1.24 | 1.27 | 1.27 | 1.44 | 1.58 | 1.66 | 0.22 | 1.37 | 1.47 | 1.57 | 1.66 | 1.78 |
| Profit before tax | 2.49 | -2.94 | 1.46 | -0.72 | 2.61 | 0.94 | 1.31 | 3.39 | 3.13 | 1.84 | 2.62 | 0.08 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.96 | 0 |
| Net Profit | 2.48 | -2.94 | 1.46 | -0.72 | 2.62 | 0.95 | 1.31 | 3.39 | 3.12 | 1.84 | 2.75 | 0.08 |
| EPS in Rs | 1.05 | -1.24 | 0.62 | -0.3 | 1.11 | 0.4 | 0.55 | 1.43 | 1.32 | 0.78 | 1.16 | 0.03 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 46 | 44 | 42 | 71 | 85 | 115 | 152 | 146 | 151 | 143 |
| Expenses | 81 | 57 | 41 | 61 | 73 | 100 | 141 | 135 | 135 | 131 |
| Operating Profit | -35 | -13 | 1 | 10 | 12 | 16 | 11 | 11 | 16 | 12 |
| OPM % | -77 | -30 | 2.9 | 14 | 14 | 14 | 7 | 8 | 11 | 8 |
| Other Income | 31 | 0 | -23 | 1 | 0 | 3 | 4 | 1 | 5 | 6 |
| Interest | 7 | 2 | 0 | 1 | 1 | 2 | 2 | 3 | 4 | 4 |
| Depreciation | 4 | 3 | 3 | 4 | 5 | 5 | 5 | 5 | 6 | 6 |
| Profit before tax | -14 | -18 | -25 | 6 | 5 | 12 | 7 | 4 | 11 | 8 |
| Tax % | 15 | 8 | 0 | 0 | 0 | 2 | 0 | 0 | -1 | — |
| Net Profit | -16 | -20 | -25 | 6 | 5 | 11 | 7 | 4 | 11 | 8 |
| EPS in Rs | -6.95 | -8.34 | -106.53 | 2.46 | 2.21 | 4.79 | 3.11 | 1.75 | 4.69 | 3.29 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 19 | 24 | 24 | 2 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 26 | 17 | -3 | 49 | 33 | 38 | 50 | 57 | 61 | 72 |
| Borrowings | 82 | 47 | 46 | 3 | 15 | 11 | 23 | 24 | 28 | 37 |
| Other Liabilities | 40 | 40 | 54 | 17 | 14 | 17 | 33 | 42 | 40 | 42 |
| Total Liabilities | 167 | 128 | 121 | 71 | 86 | 90 | 130 | 148 | 153 | 176 |
| Fixed Assets | 43 | 40 | 37 | 35 | 36 | 39 | 40 | 40 | 59 | 82 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 12 | 7 | 3 |
| Investments | 18 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 106 | 86 | 82 | 36 | 50 | 51 | 88 | 95 | 87 | 91 |
| Total Assets | 167 | 128 | 121 | 71 | 86 | 90 | 130 | 148 | 153 | 176 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 14 | -7 | -1 | -34 | -14 | 10 | 5 | 9 | 22 | 15 |
| Cash from Investing Activity | -8 | 38 | 4 | 33 | -5 | -7 | -7 | -15 | -21 | -22 |
| Cash from Financing Activity | -5 | -31 | -2 | 7 | 12 | -5 | 10 | -1 | 1 | 6 |
| Net Cash Flow | 0 | 0 | 0 | 6 | -7 | -2 | 8 | -6 | 2 | -1 |
| Free Cash Flow | 20 | 40 | -1 | -36 | -20 | 2 | -2 | -6 | 0 | -10 |
| CFO/OP | -263 | 20 | 8 | -2786 | -132 | 83 | 32 | 87 | 194 | 94 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 302 | 195 | 208 | 52 | 49 | 63 | 130 | 109 | 101 | 106 |
| Inventory Days | 118 | 102 | 122 | 208 | 154 | 185 | 129 | 125 | 127 | 129 |
| Days Payable | 164 | 265 | 517 | 229 | 107 | 113 | 165 | 149 | 140 | 139 |
| Cash Conversion Cycle | 255 | 31 | -188 | 31 | 96 | 135 | 94 | 84 | 88 | 96 |
| Working Capital Days | -36 | -108 | -210 | 89 | 121 | 123 | 104 | 92 | 74 | 74 |
| ROCE % | -6 | -35 | -21 | -3 | 10 | 11 | 16 | 9 | 8 | 12 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 88.74% | 88.43% | 88.3% | 88.3% | 88.3% | 88.3% | 75% | 75% | 75% | 75% | 75% | 75% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 8.53% | 9.34% | 9.34% | 9.34% | 9.34% | 9.34% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 6.87% | 7.66% | 7.48% | 7.37% | 7.69% | 7.66% | 11.06% | 11.62% | 12.03% | 12.13% | 12.13% | 11.97% |
| Others | 4.39% | 3.91% | 4.23% | 4.34% | 4.01% | 4.04% | 5.4% | 4.04% | 3.63% | 3.53% | 3.53% | 3.69% |
| No. of Shareholders | 7354 | 7367 | 7539 | 7391 | 7295 | 7214 | 7142 | 7283 | 7572 | 7119 | 6928 | 7062 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 5 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 304.27 | Sell |
| EMA (10) | 298.98 | Buy |
| SMA (20) | 281.82 | Buy |
| EMA (20) | 288.26 | Buy |
| SMA (50) | 258.6 | Buy |
| EMA (50) | 258.81 | Buy |
| SMA (100) | 206.48 | Buy |
| EMA (100) | 222.93 | Buy |
| SMA (200) | 167.64 | Buy |
| EMA (200) | 183.76 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 61.66 | Neutral |
| MACD (12,26,9) | 14.71 | Buy |
| Stochastic (14,3,3) | 79.16 | Neutral |
| ADX (14) | 30.57 | Buy |
| Williams %R (14) | -26.85 | Neutral |
| ATR (14) | 8.27 | Neutral |
| ROC (12) | 7.43 | Buy |
| Stoch RSI (14) | 0.63 | Buy |
| UO (7,14,28) | 56.94 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Details of the physical group meeting scheduled with the Analysts / Institutional Investors on February 12, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9 Feb - Details of the physical group meeting scheduled with the Analysts / Institutional Investors on February 12, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/418e7799-1a22-47b8-a119-c7639a4fea18.pdf) |
| 8h - Om Prakash Bhatt ceased as Independent Director of Tata Motors Passenger Vehicles Ltd effective March 8, 2026, upon term completion. | [Announcement under Regulation 30 (LODR)-Cessation 8h - Om Prakash Bhatt ceased as Independent Director of Tata Motors Passenger Vehicles Ltd effective March 8, 2026, upon term completion.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0f4e1808-f089-4a00-b9d6-4b144c7b873a.pdf) |
| 6 Feb - Newspaper publications of the financial results of the Company for the third quarter and nine months ended December 31, 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Feb - Newspaper publications of the financial results of the Company for the third quarter and nine months ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8e98d59e-5523-436a-aad0-81363540ca0a.pdf) |
| 5 Feb - Details of the physical group meeting scheduled with the Analysts / Institutional Investors on February 10, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 5 Feb - Details of the physical group meeting scheduled with the Analysts / Institutional Investors on February 10, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/768cda1a-9f5d-4936-a6cb-96c649a6a636.pdf) |
| 5 Feb - Board meeting Feb 11, 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window Jan 1–Feb 13. | [Board Meeting Intimation for Meeting Scheduled On February 11, 2026 5 Feb - Board meeting Feb 11, 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window Jan 1–Feb 13.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b096e4cb-6741-40e5-9891-9f03c4ef1c5b.pdf) |
| 5 Feb - Audio recording of Q3 and nine months ended Dec 31, 2025 results call available. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 5 Feb - Audio recording of Q3 and nine months ended Dec 31, 2025 results call available.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dc4738e2-f344-492a-99b5-29486b0b4137.pdf) |
| 27 Mar - Appointed K.S. Rao as Internal Auditor and N. Sivashankaran as Cost Auditor for FY2026-27, effective Apr 1, 2026. | [Board Meeting Outcome for Outcome For Board Meeting Held On 27/03/2026 27 Mar - Appointed K.S. Rao as Internal Auditor and N. Sivashankaran as Cost Auditor for FY2026-27, effective Apr 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a272d0e6-9316-49ca-bb39-009d41c871c5.pdf) |
| 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for quarter/FY ended Mar 31, 2026. | [Closure of Trading Window 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for quarter/FY ended Mar 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cc330aff-9df9-456b-a2aa-3e9531932870.pdf) |
| 24 Mar - 24-Mar-2026 clarification: company unaware of any event causing recent share-price movement; replied to NSE/BSE queries. | [Clarification On Price Movement 24 Mar - 24-Mar-2026 clarification: company unaware of any event causing recent share-price movement; replied to NSE/BSE queries.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/57fda81f-13b2-4281-b53f-f20edee0c5a0.pdf) |
| 23 Jan - ICRA reaffirmed ratings; long-term [ICRA]BB+ (Positive), short-term A4+; Rs.50.00 crore; outlook revised Jan 23, 2026. | [Announcement under Regulation 30 (LODR)-Credit Rating 23 Jan - ICRA reaffirmed ratings; long-term [ICRA]BB+ (Positive), short-term A4+; Rs.50.00 crore; outlook revised Jan 23, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/24e26812-9981-4046-91bd-d447997ffdcd.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d25d9149-f1b0-441d-b380-5fd84d7f2f98.pdf) |
| 2026-08-19 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f711a8eb-94af-4bc9-b8ab-a892e4890bc7.pdf) |
| 2026-08-19 | [Notice Of 31St Annual General Meeting Of The Company For The F.Y 2025-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccff51d5-8023-4419-a187-ddad1c42d9d4.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b1ff32d-c9d0-4911-b45d-5ea3fd46c81d.pdf) |
| 2026-08-13 | [Shareholder Meeting - 31St AGM On September 11 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a3bf864-8881-46f0-8519-100385de98fb.pdf) |
| 2026-08-13 | [Book Closure For 31St Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=146f87a4-fc89-427c-88cf-accf6049a7d1.pdf) |
| 2026-08-11 | [Board Meeting Outcome for The Board Meeting Held On 11/08/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab243131-b596-4422-9977-a6a2909a6453.pdf) |
| 2026-08-05 | [Board Meeting Intimation for Meeting Scheduled On August 11 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=340cb370-100d-458f-afc3-408f3889d333.pdf) |
| 2026-07-09 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9efe86c-8352-4f01-8ddf-32ce7c64cff0.pdf) |
| 2026-06-26 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af93288e-cc19-4ff7-98c5-c8a653ba3cf8.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5da3876a-86f2-4af4-b7c8-0a0efffb90ce.pdf) |
| 2026-05-29 | [Audited Financial Results For Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=571f94b2-8316-47a6-a6e8-f6b6574a33eb.pdf) |
| 2026-02-11 | [Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df9e3cc9-3a03-4f4a-85c0-06eb4c1250b3.pdf) |
| 2025-11-11 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eac122d-dc0b-4cfd-b2e8-18656852940b.pdf) |
| 2025-08-12 | [Unaudited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94ab99b2-5474-4253-9183-8e8712089137.pdf) |
| 2025-05-26 | [Audited Financial Results For The Quarter & Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c83770de-43dd-45d0-8284-76f7a45e2481.pdf) |
| 2025-02-06 | [Unaudited Financial Results For The Quarter And Nine Months Ended 31/12/2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9a908db-934c-4781-9fc3-db76362112d9.pdf) |
| 2024-11-11 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 11/11/2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb15c923-90fa-49eb-a515-bb695b49351b.pdf) |
| 2024-11-11 | [Unaudited Financial Results For The Quarter Ended 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc8c8c54-7062-45a3-a7de-09516e8012d1.pdf) |
| 2024-08-13 | [Unaudited Financial Results For The Quarter Ended 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26c45804-7d01-4e2d-9909-a2593c7c9f73.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e6684a03-5a4d-4c7a-8da0-d5b2c52ec7d1.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b24117dc-df34-49c5-b2d7-1b1aa135a1fc.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b95fcfc0-d452-417f-bb4f-e20ea498ad12.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dfe41f3c-ac3b-44b4-8fb0-ed1053c02ac9.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3e09439f-c4dc-425b-8426-8cb2cfabbec4.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/157fab8e-e33c-4f7e-af09-dd3b05c995af.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cfd0020f-d9cc-4148-9606-10eb86705ffd.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f4edb2c0-78a7-4290-8dea-57f978bb853d.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8f9c4280-a237-4f49-9330-8a4e248ec7aa.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d63bde0d-0952-4676-88a6-6d33b4bb2fc1.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1682_BAFNAPHARM_2012_2013_12092013164132.zip) |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_792_TATAMOTORS_2012_2013_29072013120804.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/48758623-f900-4e76-aaf3-6abdd286e369.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18f91098-8691-409d-b771-808c48964a4f.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/171bcaf8-6799-49a7-bbee-e844191fdadf.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0913b647-b205-4a3c-ad9b-8c493f97f972.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3b9b906c-6acb-4984-a146-43fb3c78d516.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b089df52-72ff-4b10-9c63-8375fa1f7d7e.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532989/73500532989.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500570/73198500570.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:57:10.064Z.